Abstract X11/Mint 1 and X11-like (X11L)/Mint 2 are neuronal adaptor protein to regulate trafficking and/or localization of various membrane proteins. By analyzing the localization of neuronal membrane proteins in X11-, X11L-, and X11/X11L doubly deficient mice with membrane fractionation procedures, we found that deficient of X11 and X11L decreased the level of glutamate receptors in non-PSD fraction. This finding suggests that X11 and X11L regulate the glutamate receptor micro-localization to the extrasynaptic region. In vitro coimmunoprecipitation studies of NMDA receptors lacking various cytoplasmic regions with X11 and X11L proteins harboring domain deletion suggest that extrasynaptic localization of NMDA receptor may be as a result of the multiple interactions of the receptor subunits with X11 and X11L regulated by protein phosphorylation, while that of a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor subunits is not dependent on the binding with X11 and X11L proteins. Because the loss of X11 and X11L tends to impair the exocytosis, but not endocytosis, of glutamate receptors, NMDA receptors are likely to be supplied to the extrasynaptic plasma membrane with a way distinct from the mechanism regulating the localization of NMDA receptors into synaptic membrane region. Reduced localization of NMDA receptor into the extrasynaptic region increased slightly the phosphorylation level of cAMP responsible element binding protein in brain of X11/X11L doubly deficient mice compare to wild-type mice, suggesting a possible role of X11 and X11L in the regulation of signal transduction pathway through extrasynaptic glutamate receptors. Address correspondence and reprint requests to Toshiharu Suzuki, Laboratory of Neuroscience, Graduate School of Pharmaceutical Sciences, Hokkaido University, Kita-12 Nishi-6, Kita-ku, Sapporo 060-0812, Japan. E-mail: tsuzuki@pharm.hokudai.ac.jp
X11/Mint1/Lin-10 and X11L/Mint2 proteins are extensively expressed in CNS neurons (Tomita et al. 1999; Motodate et al. 2016 ) and contain one phosphotyrosine-binding (PTB) and two postsynaptic density (PSD) 95/discs-large/zona occludens-1 (PDZ) domains. The structures of X11s are evolutionarily conserved in other animal species (Foletti et al. 1999; Hase et al. 2002) , suggesting the critical functions in neurons. The X11s regulate the intracellular membrane trafficking of membrane proteins. In vivo, X11L associate with amyloid b-protein precursor (APP) and inhibit its entry into detergent-resistant membrane microregions in neurons (Saito et al. 2008) . X11 facilitates the cell surface localization of apolipoprotein E receptor 2 (Minami et al. 2010) . X11s also regulate the trafficking of glutamate receptors in vitro (Setou et al. 2000; Stricker and Huganir 2003; Glodowski et al. 2005) . However, it is unclear if X11s regulate the plasma membrane localization of glutamate receptors.
Glutamate receptors are classified as N-methyl-D-aspartate (NMDA) receptors, a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors, and kainate receptors (Collingridge et al. 2009 ). Various scaffold proteins regulate the localization of glutamate receptors to dendritic spines, especially for AMPA receptors (Tomita et al. 2005; Waites et al. 2009; Sumioka et al. 2011; Heisler et al. 2014; Fiuza et al. 2017) . Glutamate receptors localize in both synaptic and extrasynaptic regions along with distinct roles. Signaling via extrasynaptic NMDA receptors occurs independently of signaling through synaptic NMDA receptors, and the unregulated signals from extrasynaptic NMDA receptors activate proapoptotic pathways (Snyder et al. 2005; Bordji et al. 2010; Milnerwood et al. 2010; Lombroso et al. 2016) . However, little is known about the molecular mechanism(s) underlying extrasynaptic receptor localization. Previous reports suggest that X11s function to localize AMPA receptors (Stricker and Huganir 2003; Glodowski et al. 2005) . Here, to address the roles of X11s in regulating the localization of NMDA and AMPA receptors, we analyzed the micro-localization of glutamate receptors in X11s gene-deficient mice.
Methods

Animals
Animal studies were performed based on ARRIVE guidelines (approved #13-0096 in Hokkaido University). Mice were housed in a specific pathogen-free environment in temperature-controlled (23°C) room under a 12 h light and dark cycle and fed with diet and water freely. Usually 3-6 month aged mice were used for analysis. The original X11-KO (RRID:MGI:3611777, Mori et al. 2002) and X11L-KO (RRID:MGI:3697817, Sano et al. 2006) mice were backcrossed to C57BL/6J mice (RRID:IMSR_JAX:000664; CLEA-Japan, Tokyo, Japan) more than 15 times. The respective X11-KO and X11L-KO mice were mated to generate double-KO mice. Almost 50% of the double-KO mice were died at postnatal day 0, thus, small numbers of double-KO mice survived during several months were examined (Saito et al. 2008) . C57BL/6J mice were used as the WT control. Mouse genotypes were determined (Saito et al. 2008) . For X11 allele identification, the PCR primers of 5'-tgggagggtgaacgctatac-3' and 5'-ctcactgcgcgctcatttg-3' was used for WT, while that of 5'-ggaatgtttccacccaatgtcg-3' and 5'-aggtgagatgacaggagatc-3' was used for the mutant. For X11L allele identification, the PCR primers of 5'-acatagcacacggtggtgcacat-3' (WT) and 5'-gtcgacggtatcgataagct-3' (mutant) were used with the common primer 5'-tgagtcctctctggaggtct-3'. The PCR products specific to the wildtype allele show 250 bp for X11 and 550 bp for X11L, and those to the targeted/KO allele indicate 540 bp for X11 and 310 bp for X11L (http://www.jbc.org/content/suppl/2008/10/10/M801353200.DC1/ SupplyInfo-Saito.pdf). Mice were discriminated genetically with individual identified numbers, and no randomization and blinding were performed. Mice were sacrificed by cervical dislocation to harvest brain.
Antibodies, immunoblot analysis and Phos-tag-based assay A rabbit polyclonal anti-X11 UT153 antibody (Saito et al. 2008 ) was used and this antibody can be shared upon request. Commercially available antibodies; Mouse monoclonal anti-X11/Mint1 (1 : 500, Cat#611028, RRID:AB_398341), anti-flotillin-1 (1 : 1000, Cat# 610821, RRID:AB_398140), anti-PSD95 (1 : 1000, Cat#610495, RRID:AB_397861), anti-BIP/GRP78 (1 : 1000, Cat#610979, RRID: AB_398292), anti-syntaxin 6 (1 : 1000, Cat#610636, RRID:AB_ 397966), anti-N-cadherin (1 : 2000, Cat#610920, RRID: AB_2077527), anti-GluN1(1 : 1000, Cat#556308, RRID: AB_396353), and anti-GluN2B (1 : 1000, Cat#610416, RRID:AB_ 397796) antibodies were purchased from BD Biosciences (San Hose, CA, USA). Rabbit monoclonal anti-X11L/APBA2 [D8A6] (1 : 1000, Cat#12731S), anti-phosphoCREB (Ser133) [87G3] (1 : 1000, Cat# 9198, RRID:AB_2561044), and mouse monoclonal anti-CREB [86B10] (1 : 1000, Cat#9104S, RRID: AB_10691832) antibodies were purchased from Cell Signaling Technology Inc (Danvers, MA, USA). Mouse monoclonal anti-FLAG M2 (1 : 2000, Cat#F1804, RRID:AB_262044; Sigma-Aldrich, St. Louis, MO, USA), anti-GFP (1 : 1000,Cat# 598, RRID:AB_591819; MBL, Nagoya, Japan), antia-tubulin (1 : 2000, Cat#017-25031; Wako, Osaka, Japan), and antisynaptophysin (1 : 1000, D-4, Cat#sc-17750, RRID: AB_628311; Santa Cruz Biotechnology, Dallas, TX, USA) antibodies were purchased, as were rabbit polyclonal anti-GluN2A (1 : 1000, Cat#480031; Invitrogen, Carlsbad, CA, USA), anti-GluA1 (1 : 1000, Cat#AB1504; Millipore, Berlington, MA, USA), and anti-GluA2/3 (1 : 1000, Cat#AB1555; Millipore).
The amount of protein was measured using a bicinchoninic acid protein assay kit (Cat#23225; Thermo Fisher Scientific, Waltham, MA, USA), and separated with a Tris-glycin buffered sodium dodecyl sulfate (SDS) polyacrylamide gel (8% polyacrylamide except for Fig. 7 , in which 12.5% acrylamide gel was used for CREB and Histone H3) electrophoresis (sodium dodecyl sulfatepolyacrylamide gel electrophoresis) and transferred onto nitrocellulose membrane (P/N66485, Paul Corp., Pensacola, FL, USA) for immunoblotting. Membranes were blocked in 5% non-fat dry milk (barcode 4 902220 354665, Morinaga Milk Industry, Tokyo, Japan) in TBS-T (20 mM Tris-HCl [pH 7.6], 137 mM NaCl, 0.05% Tween 20 [sc-29113, Nacalai tesque, Kyoto Japan]), probed with indicated antibodies in TBS-T, and washed with TBS-T. Immunoreactive proteins were detected using Clarity Western ECL substrate (Cat#170-5061; Bio-Rad, Hercules, CA, USA) and quantitated on an LAS-4000 (FUJIFILM, Tokyo, Japan). Results are derived from independent experiments, and the numbers of experiments (n) are indicated in the figure legends. Okadaic acid (OA) (158-03273; Wako, Osaka, Japan) was purchased. Cells were lysed with HBS-T buffer (10 mM HEPES [pH7.6], 150 mM NaCl, 0.5% Triton X-100) including a protease inhibitor mixture (PIM) (5 lg/mL chymostatin (Cat# 4063; Peptide Institute Osaka, Japan), 5 lg/mL leupeptin (Cat# 4041; Peptide Institute), and 5 lg/mL pepstatin A (Cat# 4397; Peptide Institute). The cell lysates (approximately 10 lg protein) were treated with or without lambda protein phosphatase ([kPPase] >400 unit)(Cat# P9614; Sigma-Aldrich) at 30°C for 4 h and analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis in the presence or absence of Phos-tag (Cat# 304; Wako). Proteins were transferred onto nitrocellulose membrane and probed with anti-FLAG M2 antibody (1 : 2000).
Fractionation and immunoprecipitation
Mouse cerebral cortex and hippocampus tissues were homogenized (25 strokes of a Dounce homogenizer) in eight volumes of buffer A (5 mM HEPES [pH 7.6], 0.32 M sucrose) containing PIM and 1 mM Na 3 VO 4 plus 5 mM NaF. The homogenate was centrifuged at 1000 g for 10 min at 4°C. The supernatant (PNS) was collected and centrifuged at 13 800 g for 20 min at 4°C. The precipitate (P2 fraction) was resuspended in 1 mL of buffer A and layered in a tube containing a discontinuous gradient solution of 0.85, 1.0, and 1.2 M sucrose in 5 mM HEPES (pH 7.6) combined with PIM and centrifuged at 82 500 g for 2 h at 4°C (SW41Ti; Beckman Coulter, Brea, CA, USA). The band between 1.0 and 1.2 M sucrose was collected as the synaptosomal fraction and diluted 3-fold with 6 mM Tris-HCl (pH 8.0) buffer. Triton X-100 was added to a final concentration of 0.5%, and the lysate was left on ice for 15 min. The lysate was then centrifuged at 32 000 g for 20 min at 4°C. The supernatant was collected as the non-PSD fraction, and the precipitate was washed with 6 mM Tris-HCl (pH 8.0) buffer containing 0.5% Triton X-100 and then centrifuged at 32 000 g for 20 min at 4°C. The pellet was collected as the PSD fraction and lysed with 6 mM Tris-HCl (pH 8.0) buffer containing 0.5% Triton X-100 and 0.5% sodium dodecyl sulfate.
For the coimmunoprecipitation study with the non-PSD fraction, the synaptosomal preparation including 1.2 M sucrose was diluted to 0.32 M sucrose with 5 mM HEPES (pH 7.6) buffer and centrifuged at 13 800 g for 20 min at 4°C. The precipitate was resuspended in 0.12 volumes of 6 mM Tris-HCl (pH 8.0) buffer. Triton X-100 was added to a final concentration of 0.5% and centrifuged at 32 000 g for 20 min at 4°C to remove the PSD fraction. Antibodies were added to the non-PSD fraction and rotated overnight at 4°C. Dynabeads protein G (Cat#10004D; Invitrogen) were added to the mixture and further rotated for 2 h at 4°C. The beads were washed three times with 6 mM Tris-HCl (pH 8.0) buffer containing 0.5% Triton X-100.
For nuclear fractionation, the precipitate generated after centrifugation at 1000 g for 10 min was suspended in buffer HB (10 mM HEPES [pH 7.6] containing 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 1 mM dithiothreitol, 5 mM NaF, 1 mM Na 3 VO 4 , and 5 mM sodium pyrophosphate). After incubating on ice for 15 min, Nonidet P-40 (NP-40) was added to a final concentration of 0.625%. The lysate was centrifuged at 11 000 g for 1 min at 4°C. The precipitate was washed with 0.625% NP-40 in buffer HB and centrifuged three times at 11 000 g for 1 min at 4°C. Finally, the precipitate was resuspended with 10 mM Tris-HCl (pH 7.4) buffer containing 1% sodium dodecyl sulfate.
For iodixanol density gradient fractionation, mouse cerebral cortex and hippocampus tissues were homogenized in eight volumes of a homogenization buffer (20 mM Tris-HCl [pH 7.6], 0.25 M sucrose, 1 mM EDTA, and 1 mM EGTA) containing PIM (25 strokes of a Dounce homogenizer), followed by passing (20 times) through a 21 G needle. The homogenate was then centrifuged at 1000 g for 10 min at 4°C, and the supernatant was collected (PNS). An equal volume of 50% iodixanol was added to the PNS in a centrifugation tube, and iodixanol solutions (20%, 18.5%, 16.5%, 14.5%, 12.5%, 10.5%, 8.5%, 6.5%, and 5%) were layered on top, one over another. The sample was centrifuged at 125 000 g for 20 h at 4°C (SW41Ti). Samples (500 lL each) were collected from top to bottom and analyzed by immunoblotting. Iodixanol reagents were prepared from OptiPrep 60%(w/v) (Cat#1114542; Alere Technologyies AS, Oslo Norway).
Plasmids
The plasmids pcDNA3.1-FLAG-X11, pcDNA3.1-FLAG-X11L, pcDNA3.1-FLAG-X11L-PTB+C, pcDNA3.1-FLAG-X11L-N+PTB, and pcDNA3.1-FLAG-X11L-N have been described (Tomita et al. 1999; Araki et al. 2003; Taru and Suzuki 2004) . pEGFP-N1-GluN1-GFP and pRK5-EGFP-GluN2B were provided by R. L. Huganir. Mutant plasmids were prepared by PCR technologies; pcDNA3.1-FLAG-X11-PTB+C encodes FLAG-X11-PTB+C, which lacks amino acids 1-456; pcDNA3.1-FLAG- Statistical significance was analyzed with four mice, respectively, (n = 4; *p < 0.05; **p < 0.01). In all figures, 'n' represents numbers of independent experiment and the number is equal to the number of mice. (c) Quantification of N-Cadherin at cell surface. The band density was quantified, and the relative ratio was compared to WT (a reference value of 1.0). Data represent the means AE SEs. No statistical significance was observed.
X11DPTB encodes FLAG-X11DPTB, which lacks amino acids 453-621; pcDNA3.1-FLAG-X11DPDZ1 encodes FLAG-X11DPDZ1, which lacks amino acids 649-739; pcDNA3.1-FLAG-X11DPDZ2 encodes FLAG-X11DPDZ2, which lacks amino acids 749-827; pcDNA3.1-FLAG-X11-N+PTB encodes FLAG-X11-N+PTB, which lacks 189 C-terminal amino acids; pcDNA3.1-FLAG-X11-N encodes FLAG-X11-N, which includes 456 Nterminal amino acids; pcDNA3.1-FLAG-X11LDPTB encodes FLAG-X11LDPTB, which lacks amino acids 368-555; pcDNA3.1-FLAG-X11LDPDZ1 encodes FLAG-X11LDPDZ1, which lacks amino acids 561-651; pcDNA3.1-FLAG-X11LDPDZ2 encodes FLAG-X11LDPDZ2, which lacks amino acids 661-739. These plasmids are available for researchers. pcDNA3.1-GluN1 was constructed from pEGFP-N1-GluN1-GFP. The inserted cDNA was subjected to PCR, and the PCR product was cloned into the HindIII/ BamHI sites of the pcDNA3.1. pcDNA3.1-GluN1D834-938 encodes GluM1, which lacks amino acids 834-938. pRK5-EGFPGluN2BD1316-1482, pRK5-EGFP-GluN2BD1141-1482, pRK5-EGFP-GluN2BD1011-1482, and pRK5-EGFP-GluN2BD839-1482 were constructed from pRK5-EGFP-GluN2B. The inserted cDNAs were subjected to PCR, and the PCR products were cloned into the XhoI/BamHI sites in pRK5-EGFP-GluN2B. pcDNA3.1-FLAG-X11-IAQA encodes human X11 which carries AAAA amino acid sequence substitution for 666-ILGV-669 in PDZ1 and 758-QLGF-761 in PDZ2, and pcDNA3.1-FLAG-X11L-IAQA encodes human X11L carries AAAA amino acid sequence substitution for 573-ILGV-576 in PDZ1 and 665-QLGF-668 in PDZ2 (Long et al. 2005) .
Cell culture, protein expression and coimmunoprecipitation Neuro2a (N2a) cells (Cat# CCL-131, RRID: CVCL_0470: ATCC; Manassas, VA, USA) were cultured in Dulbecco's modified Eagle's medium (Cat#044-29765; Wako) supplemented with 5% (v/v) heat-inactivated fetal bovine serum (Cat#2916754, Lot M7466; MP Biomedicals, Solon, OH, USA). The cell line is not listed by International Cell Line Authentication Committee (ICLAC). Contamination was routinely tested by DNA staining and cell morphology. Cell lines derived from mouse show a lot of speckles in the nucleus by 4',6-diamidino-2-phenylindole (Cat#D9542; Sigma-Aldrich) stain, while human cell lines have less (https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcb.10235). Furthermore, we confirm neuron-like cell differentiation in medium without fetal bovine serum. These examinations indicate that cells used in our study are the neuronal cell line derived from mouse and we do not use other mouse cell lines usually, although we cannot exclude perfectly a possibility that our N2a cell lines may be contaminated. To express the proteins, 8 9 10 5 cells in a six-well dish were transiently transfected with 0.1-1.2 lg of each plasmid with Lipofectamine 2000 (Cat#11668019; Invitrogen), and cultured for 24 h. Cells were washed with a phosphate buffered saline (10 mM sodium phosphate, 137 mM NaCl, 27 mM KCl) and lysed with HBS-T (10 mM HEPES [pH 7.6], 150 mM NaCl, 0.5% Triton X-100, 5 mM NaF, 1 mM Na 3 VO 4 , plus PIM) by rotating for 30 min at 4°C. In a separate experiment, cells were treated with OA (400 nM) for 3 h. The cell lysates were centrifuged at 19 000 g for 16 min at 4°C, and the supernatant was prepared as a crude lysate. Anti-FLAG M2 affinity gel (Cat#A2220, RRID: AB_10063035; Sigma-Aldrich) was added to the crude lysate and rotated overnight at 4°C. The resin was washed with HBS-T, and bound proteins were analyzed by immunoblotting.
Statistical analysis
Data are expressed as the means AE SEs. Statistical differences were assessed using one-way ANOVAs combined with the Tukey-Kramer post hoc test and Dunnett's test for multiple comparisons (Statcel 4; add-in software for Excel, Microsoft, or GraphPad Prism 4 software) or unpaired two-tailed Student's t tests for two comparisons. A p value of < 0.05 was considered significant. No sample size calculation and no tests for normal distribution or outliers were performed. The study was not pre-registered.
Results
Decreased level of surface glutamate receptor in brains of double-KO mice Glutamate receptors expression at the cell surface is regulated by interactions with various proteins (Chung et al. 2004; Tomita et al. 2005; Zhang et al. 2008; Jeyifous et al. 2009; Waites et al. 2009; Sumioka et al. 2011; Fiuza et al. 2017) including X11s (Setou et al. 2000; Stricker and Huganir 2003; Glodowski et al. 2005) . Because it remains unclear whether X11s regulate the level of glutamate receptors in vivo, we analyzed membrane localization of NMDA and AMPA receptors in the hippocampus of X11-KO, X11L-KO, and X11/X11L-double KO mice ( Fig. 1 and Figure S1 ). Total amounts of NMDA receptor subunits (GluN1, GluN2A, and GluN2B) and AMPA receptor subunits (GluA1 and GluA2/3) in hippocampus lysates from mutant and WT mice were similar ( Figure S1a, b) . Biotinylated surface proteins in acute brain slice preparations were detected by immunoblotting. N-cadherin was concentrated within the surface fraction but not intracellular calnexin, syntaxin 6, and synaptophysin, nor the cytosolic a-tubulin. Recovery of these intracellular proteins was below 3% in the surface fraction compared to 20-40% recovery of cell surface resident receptors ( Figure S1c ). Using this biotinylated surface fraction, we quantified the expression of glutamate receptors on the plasma membrane ( Fig. 1a and b) . GluN1 levels at the cell surface were significantly lower in X11L-KO and double-KO mice. GluA2/3 level was also lower in X11L-KO mice. The levels of other glutamate receptor subunits showed a tendency toward decreases in three mutant mice, although no significance was detected. Cell surface level of N-cadherin did not change remarkably (Fig. 1c) . The data indicate that X11s play roles in regulating glutamate receptor localization to the cell surface.
The decrease in cell surface glutamate receptors is not caused by an aberrant intracellular membrane vesicle trafficking with X11s deficiency ( Figure S2 ). Glutamate receptor subunits in subcellular membrane fractions of hippocampus and cerebral cortex tissues from WT and mutant mice were detected by immunoblotting ( Figure S2a ). Syntaxin 6 (a trans-Golgi marker) and GRP78 (an endoplasmic reticulum marker) are recovered in fraction numbers 9-14 and 14-20 for both WT and KO mice. Intracellular membrane distributions of all glutamate receptor subunits were not significantly different between WT and mutant mice ( Figure S2b ). Deficiency of X11s in each sample was confirmed ( Figure S2c) .
X11s regulate the level of extrasynaptic glutamate receptors
Glutamate receptors localize at both synaptic and extrasynaptic regions; therefore, X11s may regulate their microlocalization within or around synapses. We prepared PSD and non-PSD fractions, which correspond to synaptic and extrasynaptic regions, respectively, from synaptosomal fractions of hippocampus and cerebral cortex tissues from WT and mutant mice and quantified the amounts of glutamate receptor subunits ( Fig. 2 and Figure S3 ). Biochemically, PSD fractions contained synaptic glutamate receptors, and non-PSD fractions contained largely extrasynaptic receptors ( Figure S3a ). First, we examined the distribution of X11s together with each of the glutamate receptor subunits by immunoblotting samples from WT mice ( Figure S3b) ; the percent recovery of the proteins relative to the total amounts in the lysate was calculated ( Figure S4 ). X11s were recovered from the non-PSD fraction greater than those from the PSD fraction ( Figure S4a, right) . When equal amounts of protein are loaded (10 lg per lane), the immunoblot for X11L reveals stronger band densities in the PSD fraction than in the non-PSD fraction ( Figure S3b) ; however, the sample volume for the non-PSD fraction is much larger (Figure S4e ), indicating that the bulk of X11L was recovered in the non-PSD fraction.
The distribution ratios of glutamate receptor subunits were calculated ( Figure S4 ). Whereas GluN1 was recovered equally from both PSD and non-PSD fractions, GluN2A was recovered predominantly from the PSD fraction and more GluN2B was recovered from the non-PSD fraction ( Figure S4a , right), in accordance with a previous observation that predominantly GluN2A is synaptic and GluN2B is extrasynaptic (Groc et al. 2006) . This confirms that the PSD fraction corresponds to the synaptic region and the non-PSD region largely contains the extrasynaptic region, although the biochemical fractionation may also include presynaptic membranes.
Glutamate receptors and X11s in the PSD and non-PSD fractions were analyzed and quantified in KO mice by immunoblotting (Fig. 2) . The respective band densities were standardized to the densities of PSD95 in the PSD fraction and flotillin-1 in the non-PSD fraction. These PSD-or non-PSD resident proteins did not change their levels in WT and mutant mice (Fig. 2e) . In KO mice, the levels of glutamate receptor subunits in the PSD fraction were not significantly different ( Fig. 2a and b) , while the levels of glutamate receptor subunits in the non-PSD fraction were significantly lower ( Fig. 2c and d) . When compared with levels in WT mice, the level of GluN1 decreased in X11L-KO and double-KO mice significantly, and the level in X11-KO mice tends to decrease. GluN2B decreased in double-KO mice significantly. Levels of GluA1 and GluA2/3 did not change in mutant mice significantly, although the level of GluA2/3 tended to decrease in non-PSD fraction along with the inverse increase tendency in PSD fraction. X11s regulate the level of extrasynaptic glutamate receptors in vivo and tend to compensate for each other in this function.
X11s associate with extrasynaptic but not dendritic shaft NMDA receptors The binding of X11s to glutamate receptors is controversial, because the glutamate receptors are hetero tetramer of subunits with multi-transmembrane regions and the binding of adaptor proteins may be more complex rather than the binding to the single cytoplasmic region of APP and apolipoprotein E receptor 2 (Tomita et al. 1999; Minami et al. 2010) . We first examined the binding of X11s with glutamate receptors in non-PSD fraction from WT mice (Fig. 3a) . When X11s are immunoprecipitated with their specific antibodies, GluN1, GluN2A, and GluN2B, but not GluA1 or GluA2/3, were coimmunoprecipitated. X11s associate NMDA receptors within the extrasynaptic region to regulate potentially the level of the receptors. Extrasynaptic localization of AMPA receptors may be regulated via a different mechanism.
A previous report suggested that GluN2B is transported by KIF17 through mediation of X11 in dendrite (Setou et al. 2000) , therefore, we tested the colocalization of GluN2A and GluN2B with X11L by immunostaining mouse cortical synaptosomal fractions. Non-PSD fractions (7.5 lg of protein) were analyzed described above. (d) The densities of each subunit band in (c) were quantified and standardized to the density of flotillin-1. The values were compared with those for the WT mice and statistical significance was analyzed with six mice, respectively, (n = 6; **p < 0.01; ***p < 0.005). (e) The densities of PSD95 in PSD fraction and flotillin-1 in non-PSD fraction were quantified and the relative ratio was compared to WT. No statistical significance was observed. In panels (a) and (c), the numbers indicate molecular size (kDa).
neurons ( Figure S5 ), because the binding affinity of X11L to glutamate receptors is higher than that of X11 (Fig. 3a) , and there are no suitable antibody for X11 immunostaining in mouse neurons. In dendrites, the colocalization of X11L with GluN2A and GluN2B was not observed (Figure S5a and b) . Therefore, X11s may associate with NMDA receptors in the restricted extrasynaptic region, but not in dendritic shaft, following their activation for receptor binding.
Because the expression of GluN2B and GluN1 in the non-PSD fraction of double-KO mice was significantly lower (Fig. 2c and d) , we considered that X11s predominantly regulate the membrane micro-translocation of NMDA receptors containing GluN2B subunit. The NMDA receptor containing GluN2B is present in the extrasynaptic region at higher levels than in the synaptic region (Groc et al. 2006) and is localized in the non-PSD fraction rather than in the PSD fraction ( Figure S4a ). We therefore analyzed the interactions of X11s with NMDA receptor comprising GluN1 and GluN2B ( Fig. 3b and c) . FLAG-X11 or FLAG-X11L was expressed in N2a cells with EGFP-GluN2B and GluN1 and subject to immunoprecipitation. EGFP-GluN2B and GluN1 were coimmunoprecipitated with FLAG-X11s. X11L recovered greater amounts of GluN2B and GluN1 than X11 (Fig. 3b) , which agrees with the results with the non-PSD fraction (Fig. 3a) . When FLAG-X11s were expressed in cells with either one subunit, GluN1 or EGFP-GluN2B, and the cell lysates were immunoprecipitated with anti-FLAG antibody, only GluN2B but not GluN1 was recovered with X11s ( Fig. 3c) . When EGFP alone was expressed with FLAG-X11s in cells, anti-FLAG antibody did not coimmunoprecipitate EGFP (data not shown). The results indicate that X11s preferentially associate with GluN2B, and GluN1 may interact with X11s within the heterotetoramer complex including GluN2B, although we cannot exclude a possibility that X11s may interact with glutamate receptor subunits via other neuronal proteins.
Association of X11s with the cytoplasmic region of NMDA receptors Because GluN1 and GluN2B interact with cytoplasmic proteins through their carboxy-terminal cytoplasmic region (Lin et al. 1998; Chung et al. 2004; Yi et al. 2007; Kiraly et al. 2011) , we predicted that X11s associate with these subunits through their carboxy-terminal cytoplasmic region in the heterotetramer. To examine this, we prepared mutant GluN1 and GluN2B subunits. A schematic structure of the subunits is shown (Fig. 4a) . First, we expressed various combinations of EGFP-GluN2B plus GluN1 subunits in N2a cells with FLAG-X11s (Fig. 4b-d) . Receptor interactions were examined by coimmunoprecipitation with an anti-FLAG antibody, and the receptor subunits were detected by immunoblotting (Fig. 4b ) and quantified to compare their binding abilities for X11s (Fig. 4c and d) . NMDA receptors including either wild-type subunit (GluN1/EGFPGluN2BD839-1482 or GluN1D834-938/EGFP-GluN2B) interacted with FLAG-X11s, but the interactions were moderate or weak compared with the association with receptors including both WT subunits (assigned as 1.0). Interestingly, the interactions between GluN1D834-938/ EGFP-GluN2BD839-1482 and FLAG-X11s were much weaker than those of NMDA receptors that included at least one WT subunit or were almost absent. The combination of GluN1 and EGFP-GluN2B (both wild-type subunits) showed a weaker expression of the proteins than other combinations, a result that was reproducible (see blots of EGFP-GluN2B and GluN1 in Fig. 4b lysate) . Nevertheless, the binding of NMDA receptors including both EGFP-GluN2B and GluN1 to X11s was the strongest (Fig. 4c and d) . Although X11s dominantly interact with GluN2B rather than GluN1 when either one subunit was expressed with X11s ( Fig. 3c) , the interaction of X11s with either subunit in heterotetramer is distinct from that with each subunit alone.
Next, we investigated the binding region of a GluN2B possessing the longer cytoplasmic region. We expressed various EGFP-GluN2BD mutants in N2a cells with GluN1 WT or GluN1D834-938 and either FLAG-X11 or FLAG-X11L (Fig. 4e-g ). Immunoprecipitates with an anti-FLAG antibody were detected by immunoblotting (Fig. 4e) and quantified ( Fig. 4f and g ). The amounts of GluN1 and EGFPGluN2B bound to FLAG-X11s decreased gradually in accordance with the length of the GluN2B carboxy-terminal cytoplasmic region, further suggesting that the strongest Fig. 3 Association of X11s with glutamate receptor subunits. (a) The non-PSD synaptosomal fraction (input) was prepared from WT mice (4 months old) and subjected to coimmunoprecipitation with anti-X11 and anti-X11L antibodies along with control IgG. Immunoprecipitates (IP) were analyzed by immunoblotting. The 1.5% input contained 10 lg protein. The red asterisk indicates a nonspecific product. (b) Coimmunoprecipitation of GluN1 and GluN2B with X11s (left). FLAG-X11 or FLAG-X11L was expressed in N2a cells with EGFP-GluN2B and GluN1; the cell lysates (lysate) were then coimmunoprecipitated with an anti-FLAG antibody, and the immunoprecipitates (IP) were analyzed by immunoblotting. Binding ratio of X11s to GluN2B and GluN1 (right). The band densities of EGFP-GluN2B and GluN1 in the left panel were quantified and standardized to those of FLAG-X11s in the immunoprecipitated complex. The amounts of GluN1 and EGFP-GluN2B associated with X11L were compared with the amounts of GluN1 and EGFPGluN2B associated with X11 (a reference value of 1.0). Data represent the means AE SEs. Statistical significance was analyzed with independent five experiments (n = 5; *, p < 0.05). (c) Association of X11s with GluN2B but not GluN1. FLAG-X11 or FLAG-X11L was expressed in N2a cells with either EGFP-GluN2B or GluN1, and coimmunoprecipitation was performed as described above. The numbers indicate molecular size (kDa).
association between X11s and NMDA receptors occurs when the entire carboxy-terminal cytoplasmic regions of GluN1 and GluN2B are present. This suggests that X11s interact multiply with the subunits by a greater contribution of GluN2B rather than GluN1. Combined expression of WT subunits showed a strongest interaction with X11s than other subunit combinations, regardless of a weaker expression of both receptor subunits (see blots of lysate in Figs 4b and e) .
Contribution of X11s' multiple domains in interaction with NMDA receptors Results of Fig. 4 suggest that several regions of X11s may interact with the cytoplasmic regions of both GluN2B and GluN1 subunits. We examined the regions of X11s responsible for binding to GluN1 and GluN2B (Fig. 5) . We prepared six region-deleted X11s constructs with FLAG ( Fig. 5a ), expressed them in N2a cells with GluN1 and EGFP-GluN2B. We performed a coimmunoprecipitation study using an anti-FLAG antibody and quantified the immunoprecipitated subunits by immunoblotting (Fig. 5b-g ). The deleted FLAG-X11 proteins interacted with GluN1 and EGFP-GluN2B to a similar the full-length X11 (FL) (Fig. 5b-d) . Interestingly, significantly more of the PTB+C version bound to GluN1 and GluN2B than to FL (a reference value of 1.0) (Fig. 5c and d) . The results for FLAG-X11L proteins were similar to those for FLAG-X11 proteins (Fig. 5e-g ). Conformational change in X11s by a partial deletion of the proteins may influence the binding with target membrane proteins, as observed in the binding of APP with X11L (Tomita et al. 1999) . Overall results suggest that X11s associate with GluN1 and GluN2B through multiple interactions and several domains of X11s may be involved in the interactions with receptor subunits.
Because X11s PTB+C strongly bound to GluN2B and GluN1, at least one of the binding domains of X11s is the carboxy-terminal region. Therefore, we examined the binding abilities of X11L PTB+C to various combinations of GluN2B plus GluN1 ( Figure S6 ). Various combinations of EGFP-GluN2B plus GluN1 were coexpressed with FLAG-X11L PTB+C, and the cell lysates were subject to immunoprecipitation with anti-FLAG antibody. Interestingly, the PTB+C coprecipitated both GluN1 WT and GluN1D834-938 in the presence of GluN2B WT and GluN2BD1141-1482 but not GluN2BD839-1482, suggesting that X11L PTB+C interacts preferentially with GluN2B C-terminal region.
GluN2B has a binding site to PDZ domain in its carboxyterminal tail (Sanz-Clemente et al. 2010) , therefore the PDZ domains of X11s may interact with the C-terminal tail of GluN2B. We tested this possibility using mutant GluN2B proteins, in which Ser1480 of PDZ binding motif was altered to Glu (S1480E) or Ala (S1480A) ( Figure S7a ). Phosphorylation of Ser1480 and glutamic acid substitution for Ser1480 of NR2B suppress the interaction with PSD95 (Sanz-Clemente et al. 2010). In coimmunoprecipitaion study with lysate of cells expressing FLAG-X11s with GluN2B mutants in the presence of GluN1, the mutant GluN2B carrying either S1400E or S1400A associated with X11s as did WT GluN2B. Furthermore, GluN2BDC4 lacking Cterminal PDZ-binding motif also associated with X11s.
We further examined whether PDZ domains of X11s dominantly contribute for the binding to NMDA receptors Fig. 4 The regions responsible for binding of NMDA receptors to X11s. (a) Schematic structure of the region-deleted GluN1 and EGFPGluN2B subunits. For GluN1, N-terminal amino acids 1-21 were removed. GluN1D834-938 lacks C-terminal cytoplasmic region. For GluN2B, EGFP was inserted between amino acid numbers 31 and 32. By removing the signal sequence, the amino-terminal amino acid number is 23. GluN2BD839-1482 lacks C-terminal cytoplasmic region, while other deletions, GluN2BD1316-1482, GluN2BD1141-1482 and D1011-1482, lack the cytoplasmic region partially. (b) Interactions between X11s and carboxy-terminal-deleted GluN1 and GluN2B. FLAG-X11 or FLAG-X11L was expressed in N2a cells with the indicated combination of EGFP-GluN2B plus GluN1. The cell lysates (lysate) were subject to coimmunoprecipitation with anti-FLAG antibody, and the immunoprecipitates (IP) were analyzed by immunoblotting. Black arrowheads indicate coimmunoprecipitated EGFP-GluN2B, EGFP-GluN2BD839-1482, GluN1, and GluN1D834-938 (band for EGFP-GluN2BD839-1482 recovered with FLAG-X11L is very weak, shown with a black arrowhead in longer exposed image). (c and d) Relative amounts of GluN2B (c) and GluN1 (d) associated with X11s in the indicated combination of GluN1 plus GluN2B. Amounts detected with the combination of GluN1 WT plus GluN2B WT were assigned a reference value of 1.0. The band densities in (b) were quantified and standardized against X11 or X11L in the immunocomplex. Statistical significance was analyzed with independent four experiments (n = 4; *p < 0.05; **p < 0.01; ***p < 0.001). Data represent the means AE SEs. (e) Interactions between X11s and carboxy-terminal-deleted GluN1 and GluN2B harboring cytoplasmic regions of differing lengths. FLAG-X11 or FLAG-X11L was expressed in N2a cells with the indicated EGFP-GluN2B in the presence of GluN1 WT or GluN1D834-938. The cell lysates (lysate) were coimmunoprecipitated with anti-FLAG antibody, and immunoprecipitates (IP) were analyzed by immunoblotting. Black arrowheads indicate coimmunoprecipitated EGFP-GluN2B proteins. (f and g) Relative amounts of GluN2B (f) and GluN1 (g) associated with X11 and X11L in various combinations of GluN1 WT plus EGFP-GluN2B WT, GluN1D834-938 plus GluN2B WT, GluN1D834-938 plus GluN2BD1316-1482, GluN1D834-938 plus GluN2BD1141-1482, GluN1D834-938 plus GluN2BD1011-1482, and GluN1D834-938 plus GluN2BD839-1482. The associations were compared with those with a combination of GluN1 WT plus GluN2B WT, to which the reference value was assigned as 1.0 and indicated with a relative ratio. The band densities in (e) were quantified and standardized to X11 or X11L in the immunocomplex. Statistical significance was analyzed with independent three experiments (n = 3; *p < 0.05; **p < 0.01; ***p < 0.001). In panels (b) and (e), The red asterisks indicate nonspecific products (reacting with X11 and X11L proteins) and the numbers indicate molecular size (kDa).
( Figure S7b ). Both PDZ1 and PDZ2 of X11s were invalidated from the binding to PDZ-binding motif by substituting AAAA amino acid sequence for ILGV in PDZ1 and QLGF in PDZ2 (Long et al. 2005) . This IAQA mutant of X11s, denoted as X11 m and X11Lm, could bind to GluN2B and GluN1. Interestingly, the binding of X11 m and X11Lm to GluN2B and GluN1 enhanced rather than wild-type X11s, suggesting that conformational change in X11s by amino acid substitutions in PDZ domains may enhance the interaction with NMDA receptor subunit, or relieve the autoinhibitory state of X11s (Long et al. 2005) . These studies indicate that at least PDZ domains of X11s don't dominantly contribute for the interaction with the PDZ-binding motif of GluN2B.
Protein phosphorylation regulates the interaction between X11s and NMDA receptors
The interaction between the NMDA receptor and scaffold proteins is regulated by post-translational modifications (Lussier et al. 2015) , especially by phosphorylation (Zhang et al. 2008; Sanz-Clemente et al. 2010; Won et al. 2016) . Therefore, we examined whether the phosphorylation of X11s and/or NMDA receptors can alter their interaction by treating cells with okadaic acid (OA), a protein phosphatase 1 and 2A inhibitor. Protein phosphorylation increases in cells treated with OA increases (Oishi et al. 1997; Chiba et al. 2017) , and X11s are phosphorylated (Sakuma et al. 2009; Chaufty et al. 2012; Dunning et al. 2016) . N2a cells expressing FLAG-X11s and EGFP-GluN2B plus GluN1 were treated with OA, and the cell lysates were subjected to immunoprecipitation with an anti-FLAG antibody (Fig. 6) . Amounts of EGFP-GluN2B and GluN1 bound to either FLAG-X11s decreased significantly upon OA treatment ( Fig. 6a and b) , suggesting that the binding between X11s and NMDA receptors is regulated by protein phosphorylation partially.
Phosphorylation of X11s was confirmed by Phos-tag analysis (Fig. 6c) . Protein mobility shifts of X11s were observed in cells treated with OA, which were greater in the presence of Phos-tag. Interestingly, the phosphporylationinduced shifts were also observed in cells without OA treatment compared to X11s dephosphorylated with PPase. Phosphorylation of X11s suppresses the interactions with NMDA receptors, although we cannot rule out off-target effects of OA treatment.
X11s potentially influence NMDA receptor extocytosis but not endocytosis and recycling Localization of NMDA receptors is regulated by local membrane trafficking via endocytosis or recycling (Passafaro et al. 2001; Yudowski et al. 2007; Gu and Huganir 2016) . X11s may regulate NMDA receptor localization to the extrasynaptic region via the endocytic pathway. We first quantified the levels of glutamate receptor subunits on the cell surfaces of primary cultured neurons and examined endocytosis of these subunits. Neurons treated with Sulfo-NHS-SS-biotin were incubated in a chamber (5% CO 2 /37°C) to facilitate endocytosis. The biotin labeling of cell surface proteins were removed with a reducing agent, and the cells were lysed; the biotinylated proteins were then recovered and regarded as endocytosed proteins ( Figure S8a ). Neurons not treated with a reducing agent were used to reference proteins present on the cell surface. We quantified the amounts of glutamate receptor subunits on the cell surfaces by immunoblotting ( Figure S8b-e) . Compared with those on WT neurons, the amounts of cell surface-exposed GluN1, GluN2A, GluN2B, and GluA2/3 subunits on double-KO neurons decreased significantly ( Figure S8b and c) . The band densities were standardized with respect to the density of each subunit in the lysate. The amounts of endocytosed GluN2A and GluN2B in double-KO cells also decreased significantly ( Figure S8b and d) . However, there was no difference in the ratios of endocytosed glutamate receptors to surface-expressed glutamate receptors between WT and double-KO cells ( Figure S8e ). The expression of X11s was confirmed ( Figure S8f ). The endocytic efficiency of neurons is not altered by a deficiency of X11s.
We further examined whether X11s function to the forward trafficking of NMDA receptors by regulating exocytosis. Neurons of WT and double-KO mice were analyzed with independent four experiments (n = 4; **, p < 0.01). (e) Coimmunoprecipitation of GluN1 and EGFP-GluN2B with X11L. FLAG-X11L proteins were expressed in N2a cells with EGFP-GluN2B and GluN1 and analyzed as described in panel (b). The black arrowhead indicates coimmunoprecipitated EGFP-GluN2B, and the red asterisks indicate nonspecific products (reacting with X11 and X11L proteins). (f and g) Quantification of GluN2B (f) and GluN1 (g) binding to X11L. Band densities in (e) were quantified and standardized to X11L in the immunocomplex. The values were compared with those for full-length X11L (FL) and expressed as a relative ratio with independent three experiment (n = 3; *, p < 0.05; **, p < 0.01) as described for panels (c) and (d). In panels (b) and (e), the numbers indicate molecular size (kDa). treated with or without chlorpromazine to inhibit endocytosis, and the surface localized GluN2B on dendrites were assayed ( Figure S9 ). Level of GluN2B on the surface of dendrites was significantly lower in double-KO neurons compared to it in WT as observed in Figure S8c . Treatment of neurons with chlorpromazine restored the surface localization of GluN2B in double-KO neurons at level similar to WT neurons ( Figure S9b ). The increase ratio of cell surface localization of GluN2B in double-KO neurons was greater compared to WT neurons ( Figure S9c) . The result suggests that the decreased cell-surface localization of NMDA receptors in neurons of double-KO mice may be because of the impaired exocytosis of the receptors by lacking X11s, which could not localize the sufficient amounts of receptors. In WT neurons, the sufficient amounts of NMDA receptors on cell surface may suppress more exocytosis of the receptors by X11s.
Phosphorylation level of CREB is increased in double-KO mice Extrasynaptic NMDA receptor signaling suppresses the phosphorylation and function of CREB in the nucleus (Hardingham et al. 2001 and . Therefore, the phosphorylation levels of CREB would increase in double-KO mice. The nuclear fraction from hippocampus and cerebral cortex tissues of mice yielded approximately 4% of total protein with 35% recovery of histone H3 and almost no atubulin ( Figure S10 ), and histone H3 and CREB proteins are exclusively detected in nuclear but not PNS fractions (Fig. 7a) , confirming sufficient fractionation of nuclei. We then quantitated the levels of CREB and phosphorylated CREB in nuclear fractions by immunoblotting (Fig. 7) . The phosphorylation of CREB increased significantly in double-KO mice, and tended to increase in X11-KO and X11L-KO mice. This observation also suggests a compensatory function of X11s in extrasynaptic NMDA receptor-dependent signaling. These results suggest that X11s regulate neuronal function by regulating extrasynaptic level of NMDA receptors in vivo.
Discussion
This study reports that X11s regulate the level of extrasynaptic glutamate receptors in vivo. X11s regulate the membrane vesicle trafficking of glutamate receptors (Setou et al. 2000; Stricker and Huganir 2003; Glodowski et al. 2005) , however, it is unclear whether X11s regulate the membrane localization of glutamate receptors in vivo. The levels of extrasynaptic glutamate receptors in double-KO mice decreased, indicating that both X11 and X11L regulate the level of glutamate receptors to the extrasynaptic region. The contribution of X11L to this function is greater than that of X11, and X11L binds NMDA receptors with a greater affinity than X11. The mechanisms that regulate membrane protein localization to the extrasynaptic region have not been reported. Here, we propose a possible mechanism for NMDA receptor localization.
The endocytotic and recycling pathway for GluN2A and GluN2B are normal, while exocytosis of GluN2B can be impaired in double-KO neurons. Glutamate receptors are thought to localize first to the extrasynaptic membrane region and then translocate to the synaptic region by lateral diffusion (Passafaro et al. 2001; Yudowski et al. 2007; Gu and Huganir 2016) . Contrast to this, we hypothesize that the binding of X11s to NMDA receptors following the dephosphorylation of X11s performs the forward trafficking of receptors to the extrasynaptic membrane region from intracellular receptor pools, a mechanism that is independent of the supply of receptors to the synaptic membrane region ( Figure S11 ).
Little is known about the interaction of X11s with glutamate receptors in vivo or in vitro (Setou et al. 2000; Stricker and Huganir 2003; Glodowski et al. 2005) , but our biochemical analysis suggest that X11s interact with NMDA receptors by multiple association but largely independent on the PDZ domains, at extrasynaptic/non-PSD region. This interaction to regulate extrasynaptic NMDA receptor level may be controlled by phosphorylation of X11s. Phosphorylation of X11 can induce a conformational change (Long et al. 2005; Jensen et al. 2018) . Identification of the phosphorylation site(s) is important for further understanding of the mechanisms regulating the interaction between X11s and NMDA receptors.
We did not confirm whether the physiological activity of extrasynaptic NMDA receptors in double-KO mouse brains was lower than that in WT brains. Alternatively, we detected the change biochemically. The phosphorylation level of CREB, which is negatively regulated by extrasynaptic NMDA receptors, increased in double-KO mice. This phenotype supports that extrasynaptic NMDA receptor function is lower in double-KO mice than in WT mice. This is the first report to show that X11s regulate the level and associated functionality of extrasynaptic glutamate receptors. Analyzing the extrasynaptic localization of glutamate receptors regulated by X11s could increase our understanding of neurodegenerative disorders (Snyder et al. 2005; Bordji et al. 2010; Milnerwood et al. 2010) . Densities of bands representing phosphorylated CREB (pCREB) were standardized to the densities of bands representing total CREB (a). Data from KO mice were compared with those from WT mice (a reference values of 1.0) and the relative ratio is shown. Data represent the means AE SEs. Statistical significance was analyzed with seven mice, respectively, (n = 7; *p < 0.05).
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